How has BioCryst Pharmaceuticals's interest income and other, net changed year-over-year?

BioCryst Pharmaceuticals's interest income and other, net decreased by 25.4% year-over-year, from $3.02M to $2.26M.

What is the long-term trend for BioCryst Pharmaceuticals's interest income and other, net?

Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's interest income and other, net has grown at a 27.7% compound annual growth rate (CAGR), from $5.13M to $10.67M.

BioCryst Pharmaceuticals BCRX Interest income and other, net

Interest income and other, net at other companies

Quantum Computing Inc.QUBT

$13.5M+696%

3MMMM

$49M-38.0%

FTI ConsultingFCN

$1.07M-62.2%

Provident Financial ServicesPFS

$2.7M+21.9%

Noble CorporationNE

$8.2M+346%

Idexx LaboratoriesIDXX

$597K-50.9%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's interest income and other, net?: BioCryst Pharmaceuticals (BCRX) reported interest income and other, net of $2.26M in Q1 2026.
How has BioCryst Pharmaceuticals's interest income and other, net changed year-over-year?: BioCryst Pharmaceuticals's interest income and other, net decreased by 25.4% year-over-year, from $3.02M to $2.26M.
What is the long-term trend for BioCryst Pharmaceuticals's interest income and other, net?: Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's interest income and other, net has grown at a 27.7% compound annual growth rate (CAGR), from $5.13M to $10.67M.